Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein

Journal of Biochemistry
K Mori, S Nagasawa

Abstract

We have investigated in detail the cleavage of human high molecular weight (HMW) kininogen by human plasma kallikrein and revealed the formation of a nicked kininogen and a novel kinin-free protein (KFP) as intermediate cleavage products. The cleavage of a single chain HMW kininogen (Mr=120,000) by plasma kallikrein was a three-step reaction. The first cleavage yielded a nicked kininogen composed of two disulfide-linked 62,000 and 56,000 daltons chains. The second cleavage yielded kinin and an intermediate kinin-free protein, KFP-I, which was apparently of equal size to the nicked kininogen. The third cleavage yielded a stable kinin-free protein, KFP-II, composed of two disulfide-linked 62,000 and 45,000 daltons chains. The liberation of an 8,000 daltons fragment was identified when the 56,000 daltons chain isolated by SP-Sephadex C-50 chromatography of reduced and alkylated KFP-I was cleaved by plasma kallikrein into the 45,000 daltons chain. Although the antiserum against HMW kininogen cross-reacted with low molecular weight (LMW) kininogen, the antiserum against the 45,000 daltons chain was specific for HMW kininogen. These results suggest that the antigenic determinant groups common to HMW and LMW kininogens are located in ...Continue Reading

Citations

Nov 2, 1987·European Journal of Biochemistry·M KimuraS Iwanaga
Jun 5, 1998·The Journal of Biological Chemistry·S V Torti, F M Torti
Feb 2, 1999·Clinical Reviews in Allergy & Immunology·A P KaplanM Silverberg
Apr 6, 2002·Canadian Journal of Physiology and Pharmacology·Jing-Chuan ZhangKeith R McCrae
Aug 15, 2019·Rapid Communications in Mass Spectrometry : RCM·Stephenie H DrollZhen Zhao
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J C ZhangK R McCrae
Aug 13, 2003·Journal of Thrombosis and Haemostasis : JTH·R A PixleyR W Colman
Jun 12, 2004·Free Radical Research·Shahid P BabaBilqees Bano
May 1, 1994·British Journal of Haematology·J D PageR W Colman
Jul 1, 1984·Acta Pharmacologica Et Toxicologica·H T Johansen, K Briseid
Feb 14, 2002·The Journal of Allergy and Clinical Immunology·Allen P KaplanMichael Silverberg
Jan 1, 1988·Toxicon : Official Journal of the International Society on Toxinology·Y Komori, H Sugihara
Jan 1, 1984·Thrombosis Research·A H SchmaierR W Colman
Oct 1, 1993·Thrombosis Research·Y T WachtfogelR W Colman
Sep 1, 1986·Pharmacological Research Communications·Y UchidaM Katori
Jun 5, 2007·Immunobiology·Ellinor I B Peerschke, Berhane Ghebrehiwet
Jan 1, 1986·Critical Reviews in Oncology/hematology·R W Colman, A H Schmaier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.